TW320632B - - Google Patents

Download PDF

Info

Publication number
TW320632B
TW320632B TW084110754A TW84110754A TW320632B TW 320632 B TW320632 B TW 320632B TW 084110754 A TW084110754 A TW 084110754A TW 84110754 A TW84110754 A TW 84110754A TW 320632 B TW320632 B TW 320632B
Authority
TW
Taiwan
Prior art keywords
compound
group
pyridin
item
amine
Prior art date
Application number
TW084110754A
Other languages
English (en)
Chinese (zh)
Original Assignee
Takeda Pharm Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharm Industry Co Ltd filed Critical Takeda Pharm Industry Co Ltd
Application granted granted Critical
Publication of TW320632B publication Critical patent/TW320632B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW084110754A 1994-10-11 1995-10-13 TW320632B (Direct)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP24570494 1994-10-11
JP21089395 1995-08-18

Publications (1)

Publication Number Publication Date
TW320632B true TW320632B (Direct) 1997-11-21

Family

ID=26518319

Family Applications (1)

Application Number Title Priority Date Filing Date
TW084110754A TW320632B (Direct) 1994-10-11 1995-10-13

Country Status (7)

Country Link
US (1) US5998433A (Direct)
EP (1) EP0785939A1 (Direct)
CN (1) CN1160403A (Direct)
AU (1) AU3619795A (Direct)
CA (1) CA2200469A1 (Direct)
TW (1) TW320632B (Direct)
WO (1) WO1996011201A1 (Direct)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2751644A1 (fr) * 1996-07-26 1998-01-30 Hoechst Schering Agrevo Sa Nouveaux amides aromatiques, leur procede de fabrication et leur application comme pesticides
CZ45699A3 (cs) * 1996-08-14 1999-05-12 Zeneca Limited Substituované deriváty pyrimidinu, způsob jejich přípravy a farmaceutický prostředek, který je obsahuje
US6339096B1 (en) * 1998-01-29 2002-01-15 Boehringer Ingelheim Pharma Kg Urethanes derived from azacycloalkanes, the thio and dithio analogues thereof and their use as cholesterol biosynthesis inhibitors
US6267461B1 (en) 1998-06-23 2001-07-31 James L. Dunagan Sport ball storage apparatus and method for storing and dispensing a sport ball
JP2002535334A (ja) * 1999-01-19 2002-10-22 ニューロサーチ、アクティーゼルスカブ 縮合ヘテロ環状化合物及びこれを神経変性疾患の治療に使用する方法
US20040010818A1 (en) * 2002-05-09 2004-01-15 Mcgonigle Brian Transgenic plants with a suppressed triterpene level
JP5025469B2 (ja) * 2004-06-30 2012-09-12 アサーシス, インク. セロトニン受容体モジュレーターとしての置換アゼピン誘導体
WO2007050124A1 (en) * 2005-05-19 2007-05-03 Xenon Pharmaceuticals Inc. Fused piperidine derivatives and their uses as therapeutic agents
KR101503681B1 (ko) 2006-01-19 2015-03-19 아더시스 인코포레이티드 세로토닌 5-ht2c 수용체 리간드로서의 티오페닐 및 피롤릴 아제핀 및 이의 용도
EP2658544A4 (en) 2010-12-27 2014-05-28 Univ Missouri OXIDOSQUALENZYCASE AS A PROTEINT ARGET FOR ANTICIPATED THERAPEUTICS
SG11201504749TA (en) 2012-12-21 2015-07-30 Abt Holding Co Benzazepines as serotonin 5-ht2c receptor ligands and uses thereof
WO2014159067A1 (en) 2013-03-13 2014-10-02 Abt Holding Company Thienylindole azepines as serotonin 5-ht2c receptor ligands and uses thereof
US10040804B2 (en) 2016-12-21 2018-08-07 Biotheryx, Inc. Compounds targeting proteins, compositions, methods, and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2395028A2 (fr) * 1977-06-22 1979-01-19 Centre Etd Ind Pharma Derives pyridiniques, leur preparation et leurs application therapeutique
IL71661A0 (en) * 1983-04-27 1984-07-31 Boehringer Ingelheim Kg 4-phenyl-tetrahydro-furano-pyridines,their preparation and pharmaceutical compositions containing them
FR2652579B1 (fr) * 1989-10-02 1992-01-24 Sanofi Sa Derives d'hydroxy-2 thiophene et furanne condenses avec un cycle azote, sur procede de preparation et leur application en therapeutique.
US5143919A (en) * 1990-08-17 1992-09-01 Takeda Chemical Industries, Ltd. Thienopyridine derivatives and their pharmaceutical use
KR930703327A (ko) * 1991-12-26 1993-11-29 고야 다다시 축합형 티오펜 화합물 및 그의 의약용도
US5532240A (en) * 1991-12-26 1996-07-02 Yoshitomi Pharmaceutical Industries, Ltd. Condensed thiophene compound and pharmaceutical use thereof
US5334596A (en) * 1993-05-11 1994-08-02 Merck & Co., Inc. Fibrinogen receptor antagonists

Also Published As

Publication number Publication date
US5998433A (en) 1999-12-07
CN1160403A (zh) 1997-09-24
EP0785939A1 (en) 1997-07-30
AU3619795A (en) 1996-05-02
CA2200469A1 (en) 1996-04-18
WO1996011201A1 (en) 1996-04-18

Similar Documents

Publication Publication Date Title
TWI852689B (zh) 補體因子b抑制劑及其藥物組合物、製備方法和用途
TW320632B (Direct)
JP4417622B2 (ja) Parpの阻害剤として用いるためのチエノ[2,3−c]イソキノリン
TW308594B (Direct)
KR900006853B1 (ko) 약리학적으로 활성인 피라졸로/4,3-c/피리딘의 제조방법
TW200838539A (en) Pyridopyrimidinone compounds useful in treating sodium channel-mediated diseases or conditions
US20060148831A1 (en) 1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands
US20040023970A1 (en) 1-Heterocyclylalkyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands
WO2011098035A1 (zh) 一种青藤碱衍生物、合成方法及其用途
TW200936584A (en) N-azabicyclic carboxamide derivatives, preparation and therapeutic use thereof
JP5808020B2 (ja) 2−オキソ−1−ピロリジニルイミダゾチアジアゾール誘導体
US7763636B2 (en) N-(arylalkyl)-1H-pyrrolopyridine-2-carboxamide derivatives, preparation and therapeutic use thereof
JPH09501442A (ja) 免疫抑制剤として有用な炭素環式および複素環式縮合環キノリンカルボン酸
EP2688403A1 (en) Opioid receptor ligands and methods of using and making same
JPH03215489A (ja) Paf拮抗作用を有する新規ヘトラゼピン、その製造方法及び該ヘトラゼピンを含有する医薬組成物
JPH04504709A (ja) ピロロ[1,2―a]イミダゾールおよびイミダゾ[1,2―a]ピリジン誘導体ならびにその5―リポキシゲナーゼ経路抑制剤としての使用
WO2011140817A1 (zh) 1-[(4-羟基哌啶-4-基)甲基]吡啶-2(1h)-酮衍生物及其制备方法和用途
TW517058B (en) Benzopyranopyrrole and benzopyranopyridine Α-1 adrenergic compounds
Basiri et al. Cholinesterase inhibitory activity versus aromatic core multiplicity: A facile green synthesis and molecular docking study of novel piperidone embedded thiazolopyrimidines
CN108947879A (zh) Prmt i型抑制剂及其制备方法和用途
CN106459078B (zh) 倍半萜类化合物
AU2010340745B2 (en) Sulfone compounds as 5-HT6 receptor ligands
CN113518779B (zh) 噻吩并杂环类衍生物、其制备方法及其在医药上的应用
de Farias et al. Synthesis, characterization and molecular docking study of pyrazolines synthesized from chalcones: Antioxidant and acetylcholinesterase activities
US20050101596A1 (en) Sulfonyltetrahydro-3H-benzo(E)indole-8-amine compounds as 5-Hydroxytryptamine-6 ligands